Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the…

By S. Gadgeel, L. Gandhi, Gregory Riely, A. Chiappori, H. West, Michele C. Azada, P. N. Morcos, Ruey-min Lee, L. Garcia, Li Yu and 7 more. The Lancet Oncology, 2014

649 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/ec19d4a90121ef5119a9d82c8b22b9319487abb7